ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MRVI Maravai LifeSciences Holdings Inc

8,405
-0,055 (-0,65%)
Zuletzt aktualisiert: 18:56:11
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Maravai LifeSciences Holdings Inc MRVI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,055 -0,65% 8,405 18:56:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,34 8,32 8,595 8,46
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.5.202402:59EDGAR2Form 144 - Report of proposed sale of securities
28.5.202423:19EDGAR2Form 8-K - Current report
24.5.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.5.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.5.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.5.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.5.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202414:00BWTriLink BioTechnologies collaborates with Johns Hopkins..
09.5.202422:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202422:05GLOBEMaravai LifeSciences Announces May and June 2024 Investor..
08.5.202422:09EDGAR2Form 8-K - Current report
08.5.202422:05GLOBEMaravai LifeSciences Reports First Quarter 2024 Financial..
30.4.202422:49BWTriLink BioTechnologies® et Lonza signent un contrat de..
30.4.202413:31BWTriLink BioTechnologies® and Lonza Enter into Non-exclusive..
18.4.202421:12BWTriLink BioTechnologies® annonce un nouveau site à San Diego..
18.4.202421:09BWTriLink BioTechnologies® kündigt neue Anlage in San Diego..
18.4.202413:36BWTriLink BioTechnologies® Announces New San Diego Facility..
10.4.202422:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
12.3.202421:15GLOBEMaravai LifeSciences Announces March 2024 Investor..
29.2.202423:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202422:08EDGAR2Form 8-K - Current report
22.2.202422:05GLOBEMaravai LifeSciences Reports Fourth Quarter and Full Year..
21.2.202414:00BWTriLink BioTechnologies® Solidifies IP Position with Awarded..
21.2.202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202414:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
08.2.202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29.1.202414:00GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
19.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16.11.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202314:15GLOBEMaravai LifeSciences Announces November 2023 Investor..
08.11.202323:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:11EDGAR2Form 8-K - Current report
07.11.202322:05GLOBEMaravai LifeSciences Reports Third Quarter 2023 Financial..
02.11.202311:47BWTriLink BioTechnologies® Expands Capabilities with Launch of..
17.10.202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.10.202314:15GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
29.9.202314:15GLOBEMaravai LifeSciences Hosts 2023 Investor R&D Day
19.9.202315:31GLOBEMaravai LifeSciences Chief Innovation Officer Kate Broderick..
05.9.202322:15GLOBEMaravai LifeSciences to Host 2023 Investor R&D Day
23.8.202314:15GLOBECygnus Technologies Receives 2023 R&D 100 Award for MockV®..
22.8.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202322:15GLOBEMaravai LifeSciences Announces August 2023 Investor..
08.8.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:19EDGAR2Form 8-K - Current report
07.8.202322:05GLOBEMaravai LifeSciences Reports Second Quarter 2023 Financial..
27.7.202322:11EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht